Literature DB >> 33947097

Proteolytic Cleavage of Receptor Tyrosine Kinases.

Hao Huang1,2.   

Abstract

The receptor tyrosine kinases (RTKs) are a large family of cell-surface receptors, which are essential components of signal transduction pathways. There are more than fifty human RTKs that can be grouped into multiple RTK subfamilies. RTKs mediate cellular signaling transduction, and they play important roles in the regulation of numerous cellular processes. The dysregulation of RTK signaling is related to various human diseases, including cancers. The proteolytic cleavage phenomenon has frequently been found among multiple receptor tyrosine kinases. More and more information about proteolytic cleavage in RTKs has been discovered, providing rich insight. In this review, we summarize research about different aspects of RTK cleavage, including its relation to cancer, to better elucidate this phenomenon. This review also presents proteolytic cleavage in various members of the RTKs.

Entities:  

Keywords:  cancers; caspase; metalloprotease; protease; proteolytic cleavage; receptor tyrosine kinase; secretase

Year:  2021        PMID: 33947097     DOI: 10.3390/biom11050660

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  134 in total

1.  Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.

Authors:  Jorma A Määttä; Maria Sundvall; Teemu T Junttila; Liisa Peri; V Jukka O Laine; Jorma Isola; Mikala Egeblad; Klaus Elenius
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

2.  Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

Authors:  Jaouhar Mourali; Alan Bénard; Filipe Calheiros Lourenço; Céline Monnet; Catherine Greenland; Christel Moog-Lutz; Claire Racaud-Sultan; Daniel Gonzalez-Dunia; Marc Vigny; Patrick Mehlen; Georges Delsol; Michèle Allouche
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 3.  Insulin receptor signaling in normal and insulin-resistant states.

Authors:  Jérémie Boucher; André Kleinridders; C Ronald Kahn
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

4.  Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.

Authors:  Christel Moog-Lutz; Joffrey Degoutin; Jean Y Gouzi; Yvelyne Frobert; Nicole Brunet-de Carvalho; Jocelyne Bureau; Christophe Créminon; Marc Vigny
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

5.  Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1.

Authors:  Jun Cai; Wen G Jiang; Maria B Grant; Mike Boulton
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

6.  NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.

Authors:  T A Christianson; J K Doherty; Y J Lin; E E Ramsey; R Holmes; E J Keenan; G M Clinton
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

7.  The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus.

Authors:  Hala O El Mesallamy; Nadia M Hamdy; Dina M Mostafa; Ashraf I Amin
Journal:  J Interferon Cytokine Res       Date:  2013-11-06       Impact factor: 2.607

8.  Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling.

Authors:  Anastasios Georgakopoulos; Claudia Litterst; Enrico Ghersi; Lia Baki; ChiJie Xu; Geo Serban; Nikolaos K Robakis
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

9.  Necrosis- and apoptosis-related Met cleavages have divergent functional consequences.

Authors:  R Montagne; M Berbon; L Doublet; N Debreuck; A Baranzelli; H Drobecq; C Leroy; N Delhem; H Porte; M-C Copin; E Dansin; A Furlan; D Tulasne
Journal:  Cell Death Dis       Date:  2015-05-21       Impact factor: 8.469

Review 10.  The ADAM metalloproteinases.

Authors:  Dylan R Edwards; Madeleine M Handsley; Caroline J Pennington
Journal:  Mol Aspects Med       Date:  2008-08-15
View more
  1 in total

Review 1.  Current Status and Prospects of Clinical Treatment of Osteosarcoma.

Authors:  Zong-Yuan Jiang; Ji-Bin Liu; Xiao-Feng Wang; Yu-Shui Ma; Da Fu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.